Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
BiotequeROCO:4107 84 Interest Coverage is 132.71 as of Jun. 2026, which is 7% below its 10-year median of 142.55. GuruFocus rates ROCO:4107 with a GF Score™ of 84/100 and a GF Value™ of NT$130.35 (Modestly Undervalued). Among 466 Medical Devices & Instruments companies, Bioteque ranks better than 75.54% on this metric.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's
Operating Income
by its Interest Expense. Bioteque's
Operating Income
for the
three
months ended in Jun. 2026 was NT$196 Mil. Bioteque's Interest Expense for the
three
months ended in Jun. 2026 was NT$-1 Mil.
Bioteque's interest coverage for the quarter that ended in Jun. 2026 was 132.71.
The higher the ratio, the stronger the company's financial strength is.
Good Sign:
Ben Graham prefers companies' interest coverage to be at least 5. Bioteque Corp has enough cash to cover all of its debt. Its financial situation is stable.
The historical rank and industry rank for Bioteque's Interest Coverage or its related term are showing as below:
ROCO:4107'
s Interest Coverage Range Over the Past 10 Years
Min: 50 Med: 142.55 Max: 483.96
Current: 105.74
ROCO:4107's Interest Coverage is ranked better than 75.54% of 466
companies
in the Medical Devices & Instruments industry
Industry Median: 16.91
vs ROCO:4107: 105.74
Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.
Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .
Bioteque Interest Coverage Related Terms
Bioteque Interest Coverage Historical Data
* Premium members only.
The historical data trend for Bioteque's Interest Coverage can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.
ROCO:4107 vs ISRG, BDX, MDLN: Interest Coverage Comparison
For the Medical Instruments & Supplies subindustry, Bioteque's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Bioteque Interest Coverage vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Bioteque's Interest Coverage distribution charts can be found below:
* The bar in red indicates where Bioteque's Interest Coverage falls into.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Bioteque (ROCO:4107) has a Interest Coverage of 132.71 as of Jun. 2026. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Bioteque and its competitors. This is near median its historical median of 142.55. Over the past decade, Bioteque's Interest Coverage has ranged from 50.00 to 483.96. According to the industry distribution chart, Bioteque ranks #114 out of 466 companies in the Medical Devices & Instruments industry, placing it in the top 24.5%.
Is Bioteque's Interest Coverage too high?
Bioteque's current Interest Coverage of 132.71 is near median its 10-year median of 142.55. Over the past 10 years, this metric has ranged from a low of 50.00 to a high of 483.96. The Medical Devices & Instruments industry median Interest Coverage is 16.91. Bioteque's value of 132.71 is 684.8% above this industry median. Based on the distribution chart, Bioteque ranks #114 out of 466 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Bioteque has a GF Score™ of 84/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Bioteque's Interest Coverage compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Bioteque ranks #114 out of 466 companies for Interest Coverage. This places Bioteque in the top 25% of its industry — outperforming the majority of peers. The industry median Interest Coverage is 16.91. Bioteque's value of 132.71 is 684.8% above this benchmark. Historically, Bioteque's own Interest Coverage has ranged from 50.00 to 483.96 over the past decade. While the company's 10-year median is 142.55 vs. the industry median of 16.91, Bioteque has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Coverage for a Medical Devices & Instruments company?
The median Interest Coverage among Medical Devices & Instruments companies is 16.91, based on 466 companies in the industry. Companies in the top quartile (top 25%) have a Interest Coverage significantly above this median, while those in the bottom quartile fall well below. However, Interest Coverage should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Bioteque's current Interest Coverage of 132.71 is 684.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Coverage mean?
A high Interest Coverage can signal that a stock is expensive relative to its fundamentals. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Bioteque and its competitors. For the Medical Devices & Instruments industry, the median Interest Coverage is 16.91 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Bioteque's current Interest Coverage is 132.71, which is near median its own 10-year median of 142.55. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bioteque stock overvalued right now?
Based on GuruFocus' analysis, Bioteque (ROCO:4107) is currently considered Modestly Undervalued. The stock's GF Value™ is NT$130.35, compared to a current price of NT$114.00 — trading 12.5% below its estimated fair value. The current Interest Coverage is 132.71, which is near median its 10-year median of 142.55 and 684.8% above the Medical Devices & Instruments industry median of 16.91. Bioteque's overall GF Score™ is 84/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Coverage calculated?
Interest Coverage is calculated from a company's financial statements. For Bioteque (ROCO:4107), the current Interest Coverage is 132.71 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Bioteque (ROCO:4107) Overvalued in 2026?
Based on GuruFocus' analysis, Bioteque stock appears to be undervalued.
The current stock price of NT$114.00 is trading 12.5% below its estimated GF Value™ of NT$130.35.
GuruFocus considers Bioteque to be Modestly Undervalued.
Key valuation signals for ROCO:4107:
Interest Coverage: 132.71 (near median its 10-year median of 142.55)
GF Value™: NT$130.35 vs. price of NT$114.00 (12.5% below fair value)
Industry Position: 684.8% above the Medical Devices & Instruments median (#114 of 466)
No single metric tells the full story. See the ROCO:4107 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Bioteque Corp is engaged in manufacturing, trading, and selling medical equipment and instruments. The company operates in different segments such as Manufacturing medical disposables for hemodialysis use, and selling them to dealers and retailers; Manufacturing and selling catheters for healthcare and medical PVC IV bags to medical organizations; Manufacturing and selling medical key components and inner catheters to the medical organization; and Other segment. Geographically, the company generates a majority of its revenue from Asia and the rest from North America, South America, and other regions.
84GF Score
Get the complete analysis for ROCO:4107
Interest Coverage is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:4107 has been successfully added to your 
